BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11905591)

  • 41. Videoconferencing-Based Treatment of Alcohol Use Disorders: Analyses of Nonparticipation.
    Tarp K; Mejldal A; Nielsen AS
    JMIR Form Res; 2017 Sep; 1(1):e3. PubMed ID: 30684431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patients' motives for participating in active post-marketing surveillance.
    Härmark L; Lie-Kwie M; Berm L; de Gier H; van Grootheest K
    Pharmacoepidemiol Drug Saf; 2013 Jan; 22(1):70-6. PubMed ID: 22836782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregnant womens' concerns when invited to a randomized trial: a qualitative case control study.
    Oude Rengerink K; Logtenberg S; Hooft L; Bossuyt PM; Mol BW
    BMC Pregnancy Childbirth; 2015 Sep; 15():207. PubMed ID: 26341516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey.
    Moorcraft SY; Marriott C; Peckitt C; Cunningham D; Chau I; Starling N; Watkins D; Rao S
    Trials; 2016 Jan; 17():17. PubMed ID: 26745891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attitudes of Patients With Gastrointestinal Cancers Toward Research Biopsies.
    Moorcraft SY; Begum R; Cunningham D; Peckitt C; Baratelli C; Gillbanks A; Rogers P; Nwokorie V; Chau I; Watkins D; Starling N
    Clin Colorectal Cancer; 2017 Sep; 16(3):e181-e189. PubMed ID: 27839727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altruism as a reason for participation in clinical trials was independently associated with adherence.
    Rosenbaum JR; Wells CK; Viscoli CM; Brass LM; Kernan WN; Horwitz RI
    J Clin Epidemiol; 2005 Nov; 58(11):1109-14. PubMed ID: 16223653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adult patient perspectives on clinical trial result reporting: A survey of cancer patients.
    Elzinga KE; Khan OF; Tang AR; Fernandez CV; Elzinga CL; Heng DY; Vickers MM; Truong TH; Tang PA
    Clin Trials; 2016 Dec; 13(6):574-581. PubMed ID: 27559022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy.
    Jenkins V; Fallowfield L
    Br J Cancer; 2000 Jun; 82(11):1783-8. PubMed ID: 10839291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Masculinity, alexithymia, and fear of intimacy as predictors of UK men's attitudes towards seeking professional psychological help.
    Sullivan L; Camic PM; Brown JS
    Br J Health Psychol; 2015 Feb; 20(1):194-211. PubMed ID: 24479947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Public attitudes regarding willingness to participate in medical research studies.
    Trauth JM; Musa D; Siminoff L; Jewell IK; Ricci E
    J Health Soc Policy; 2000; 12(2):23-43. PubMed ID: 11184441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomised controlled trials of palliative care - a survey of the views of advanced cancer patients and their relatives.
    White CD; Hardy JR; Gilshenan KS; Charles MA; Pinkerton CR
    Eur J Cancer; 2008 Sep; 44(13):1820-8. PubMed ID: 18550360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient perception of a long-term clinical trial: experience using a close-out questionnaire in the Studies of Left Ventricular Dysfunction (SOLVD) Trial. SOLVD Close-out Working Group.
    Henzlova MJ; Blackburn GH; Bradley EJ; Rogers WJ
    Control Clin Trials; 1994 Aug; 15(4):284-93. PubMed ID: 7956268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reasons given by patients for participating, or not, in Phase 1 cancer trials.
    Catt S; Langridge C; Fallowfield L; Talbot DC; Jenkins V
    Eur J Cancer; 2011 Jul; 47(10):1490-7. PubMed ID: 21454072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Remembering and interpreting informed consent: a qualitative study of drug trial participants.
    Searight HR; Miller CK
    J Am Board Fam Pract; 1996; 9(1):14-22. PubMed ID: 8770805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of Clinical Characteristics Between Clinical Trial Participants and Nonparticipants Using Electronic Health Record Data.
    Rogers JR; Liu C; Hripcsak G; Cheung YK; Weng C
    JAMA Netw Open; 2021 Apr; 4(4):e214732. PubMed ID: 33825838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global Public Attitudes About Clinical Research and Patient Experiences With Clinical Trials.
    Anderson A; Borfitz D; Getz K
    JAMA Netw Open; 2018 Oct; 1(6):e182969. PubMed ID: 30646218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are subjects satisfied with the informed consent process? A survey of research participants.
    Pope JE; Tingey DP; Arnold JM; Hong P; Ouimet JM; Krizova A
    J Rheumatol; 2003 Apr; 30(4):815-24. PubMed ID: 12672205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Public attitudes toward participation in cancer clinical trials.
    Comis RL; Miller JD; Aldigé CR; Krebs L; Stoval E
    J Clin Oncol; 2003 Mar; 21(5):830-5. PubMed ID: 12610181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Knowledge, Attitudes and Perceptions of Saudis towards Participating in Clinical Trials.
    Al-Tannir MA; El-Bakri N; Abu-Shaheen AK
    PLoS One; 2016; 11(2):e0143893. PubMed ID: 26848750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.